Same question across reviews · CL0049
aetiology :: Glass ionomer / ART -> Other outcome
ProposalThis cluster groups questions by review type, intervention category and outcome domain. It is a proposal pending human validation, so questions in it may differ in population, comparator or timing.
Reviews
1
Questions
13
current versions
GRADE rated
0
Review overlap (CCA)
NR
over all included studies of these reviews, not this question only
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls Kaposi's sarcoma (WHO clinical stage 4) · Children and adolescents (<18 years) · Cross-sectional (case-control; single time point) Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | Planned WHO stage 4 outcome; no eligible studies (Table 2 lists 'None'). | 0 studies | No studies |
Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls Mucosal (oral) hyperpigmentation · Children and adolescents (<18 years) · Cross-sectional (case-control; single time point) Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | OR 20.35 [3.86, 107.39] | 3 studies · 407 participants | Ungraded |
Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls Ulcerative stomatitis · Children and adolescents (<18 years) · Cross-sectional (case-control; single time point) Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | OR 28.59 [1.67, 490.32] | 1 study · 190 participants | Ungraded |
Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls Dental development / dental age (mineralization chronology) · Children and adolescents (<18 years) · Cross-sectional (case-control; single time point) Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | Three studies (Fernandes 2007, de Souza 2015, Holderbaum 2005) assessed dental age (Nolla/Willems methods); Fernandes and de Souza found no significant difference between groups; Holderbaum reported mixed sex-specific… | 3 studies | Ungraded |
Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls Recurrent oral ulcerations (WHO clinical stage 2) · Children and adolescents (<18 years) · Cross-sectional (case-control; single time point) Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | OR 6.83 [1.18, 39.53] | 3 studies · 284 participants | Ungraded |
Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls Mucocele · Children and adolescents (<18 years) · Cross-sectional (case-control; single time point) Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | OR 3.03 [0.12, 75.37] | 1 study · 190 participants | Ungraded |
Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls Chronic herpes simplex infection (WHO clinical stage 4) · Children and adolescents (<18 years) · Cross-sectional (case-control; single time point) Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | Planned WHO stage 4 outcome; no eligible studies (Table 2 lists 'None'). | 0 studies | No studies |
Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls Poor oral hygiene (simplified oral hygiene index, OHI-S > 3) · Children and adolescents (<18 years) · Cross-sectional (case-control; single time point) Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | OR 1.23 [0.73, 2.07] | 1 study · 837 participants | Ungraded |
ART/HAART duration <3 years vs ART/HAART duration >=3 years Oral candidiasis · Children and adolescents living with HIV on ART/HAART · Cross-sectional (case-control; single time point), ART/HAART duration <3 years vs >=3 years Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | OR 17.93 [3.69, 83.12] | 2 studies | Ungraded |
Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls Persistent parotid enlargement (WHO clinical stage 2) · Children and adolescents (<18 years) · Cross-sectional (case-control; single time point) Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | OR 10.36 [0.53, 201.45] | 1 study · 60 participants | Ungraded |
Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls Oral hairy leukoplakia (WHO clinical stage 3) · Children and adolescents (<18 years) · Cross-sectional (case-control; single time point) Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | OR 1.00 [0.06, 16.19] | 2 studies · 217 participants | Ungraded |
Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls Angular cheilitis (WHO clinical stage 2) · Children and adolescents (<18 years) · Cross-sectional (case-control; single time point) Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | OR 1.95 [0.16, 23.65] | 2 studies · 224 participants | Ungraded |
Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls Oral candidiasis (WHO clinical stage 3) · Children and adolescents (<18 years) · Cross-sectional (case-control; single time point) Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A… (2022) | OR 16.94 [5.06, 56.70] | 5 studies | Ungraded |